PTX encapsulated by an XG–DOX conjugate for combination therapy against multi-drug resistance-Reference-Cited by-同舟云学术

PTX encapsulated by an XG–DOX conjugate for combination therapy against multi-drug resistance

Published:2016 Issue:109 Volume:6 Page:107606-107612
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Huang Zhuli¹²³⁴⁵,Xie Xuan¹²³⁴⁵,Mukerabigwi Jean Felix¹²³⁴⁵,Wang Chang¹²³⁴⁵,Wang Shufang⁶⁷⁸⁹,Xiao Wang¹²³⁴⁵,Huang Xueying¹²³⁴⁵,Cao Yu¹²³⁴⁵

Affiliation:

1. Key Laboratory of Pesticide and Chemical Biology (Ministry of Education)

2. College of Chemistry

3. Central China Normal University

4. Wuhan 430079

5. P. R. China

6. Blood Transfusion Department

7. The General Hospital of the People’s Liberation Army

8. Beijing 100853

9. China

Abstract

A new type of targeted dual drug delivery system was designed and possesses outstanding advantages over ordinary systems, proving effective against MDR cancer cells.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA20437F

Reference30 articles.

1. Polymer conjugates as anticancer nanomedicines

2. Nanoparticles in cancer therapy and diagnosis

3. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches

4. Polysaccharides-based nanoparticles as drug delivery systems

5. T. Sonia and C. P.Sharma, in Chitosan for biomaterials I, Springer, 2011, pp. 23–53

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors;Drug Resistance Updates;2020-05

2. Diatoms embedded, self-assembled carriers for dual delivery of chemotherapeutics in cancer cell lines;International Journal of Pharmaceutics;2020-01

3. Multidrug resistance and the prospects of combination therapy;Combination Therapy Against Multidrug Resistance;2020

4. Dual-responsive core-crosslinked polyphosphoester-based nanoparticles for pH/redox-triggered anticancer drug delivery;Journal of Materials Chemistry B;2017